Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies

Alan W. Partin, Leander Van Neste, Eric A. Klein, Leonard S. Marks, Jason R. Gee, Dean A. Troyer, Kimberly Rieger-Christ, J. Stephen Jones, Cristina Magi-Galluzzi, Leslie A. Mangold, Bruce J. Trock, Raymond S. Lance, Joseph W. Bigley, Wim Van Criekinge, Jonathan I. Epstein

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1081-1087
JournalJournal of Urology
Volume192
Issue number4
DOIs
Publication statusPublished - Oct 2014

Keywords

  • prostate
  • prostatic neoplasms
  • epigenomics
  • methylation
  • biopsy

Cite this

Partin, A. W., Van Neste, L., Klein, E. A., Marks, L. S., Gee, J. R., Troyer, D. A., Rieger-Christ, K., Jones, J. S., Magi-Galluzzi, C., Mangold, L. A., Trock, B. J., Lance, R. S., Bigley, J. W., Van Criekinge, W., & Epstein, J. I. (2014). Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies. Journal of Urology, 192(4), 1081-1087. https://doi.org/10.1016/j.juro.2014.04.013